Savings are starting early! Save 25% on select tests.
Terms >
COVID-19 & Flu Test
COVID-19 & Flu Test
Detect active SARS-CoV-2 and influenza A/B infections. Included with your purchase, if your test results are positive for influenza A/B infections, an independent physician may be able to provide you with treatment options. Read moreTest details
Sample type:
Nasal swab
Preparation:
You don't need to do anything to prepare for the test, such as fasting or not taking medications.
Additional instructions will be provided during your appointment.
What
This test detects active infection with the SARS-CoV-2 virus (the virus causing COVID-19) and the influenza A and B viruses.
Who
Must be 18+ years of age to purchase.
How
Nasal swab
Schedule an appointment, then visit a Quest Diagnostics patient service center location.
About the Test
The COVID-19 and Flu test collection kit tests for SARS-CoV-2 (the virus causing COVID-19) and the influenza A and influenza B viruses.
About COVID-19 COVID-19 is highly contagious. Cases of COVID-19 range from mild to severe. Most people infected with this virus have mild symptoms. Some people who are infected don’t have any symptoms and don’t feel sick but can still transmit the virus to others. More severe cases of COVID-19 have been seen in older adults and those with weakened immune systems or pre-existing health issues. However, serious illness can also occur in younger adults. About the flu Flu is a contagious respiratory illness caused by the influenza A and B viruses. It infects the nose, throat, and sometimes the lungs. There are 2 main types of influenza (flu) viruses: Types A and B. Some people, such as those who are 65 or older, young children, and people with certain health conditions, such as asthma and diabetes, are at higher risk of serious flu complications.
How it works
questhealth.com offers 100+ consumer-initiated Quest Diagnostics lab tests to empower you to have more control over your health journey. Choose from a variety of test types that best suit your needs.
FAQs
COVID-19 and the flu are both respiratory viruses, but COVID-19 is caused by the SARS CoV-2 virus (severe acute respiratory syndrome coronavirus 2), and the flu is caused by the influenza virus. Both are very contagious, but symptoms usually appear much sooner with the flu.
This test has been authorized by the FDA under an Emergency Use Authorization (EUA). This means that while Quest Diagnostics has validated the test and has the data to believe the test and the collection kit are accurate, this test has not been FDA-cleared or -approved; This test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the detection of nucleic acid from SARS-CoV-2 and influenza A virus and influenza B virus, not for any other viruses or pathogens; and, this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use on in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(B)(1) of the Act, 21 U.S.C. § 360BBB-3(B)(1), unless the authorization is terminated or revoked sooner. Additional studies need to be conducted for this test and others like it to be FDA cleared or approved.
The COVID-19 and Flu Test is a molecular or nucleic acid test (for example “PCR” test), which checks for genetic material (viral RNA) produced by the virus. This test uses a nasal swab collection kit, which is authorized by the FDA under an Emergency Use Authorization (EUA), and will be used to test for COVID-19, an illness caused by the coronavirus SARS-CoV-2, as well as influenza A and B. The test does not check for influenza C.
Your appointment will be for observed self-collection of a nasal swab sample at a drive-thru location. You’ll swab your nose while in your vehicle, observed by a trained healthcare professional to ensure the sample is collected correctly. Then you’ll drop the sealed sample into a container on your way out of the drive-thru location. Appointments are required to complete your purchase. Drive-thru locations may be limited or unavailable in some areas, and collection hours may vary by location.
You may be able to use your FSA or HSA funds to purchase lab tests at questhealth.com. Please review your FSA/HSA plan or check with a tax professional to confirm specific requirements for individual eligibility.
Our references
The IgG and IgM antibody tests are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Results are for the detection of SARS CoV-2 antibodies. IgG and IgM antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Individuals may have detectable virus present for several weeks following seroconversion. Negative results do not preclude acute SARS-CoV-2 infection. If acute infection is suspected, molecular testing for SARSCoV-2 is necessary. The tests should not be used to diagnose acute SARS-CoV-2 infection. False positive results for the test may occur due to cross-reactivity from pre-existing antibodies or other possible causes. The sensitivity of the IgM test early after infection is unknown. Due to the risk of false positive results, confirmation of positive results should be considered using a second, different IgM assay or an IgG assay. Samples should only be tested for IgM from individuals with 15 days to 30 days post symptom onset. SARS-CoV-2 antibody negative samples collected 15 days or more post symptom onset should be reflexed to a test that detects and reports SARS-CoV-2 IgG.
- This test has not been FDA cleared or approved;
- This test has been authorized by FDA under an EUA for use by authorized laboratories;
- This test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus, and not for any other viruses or pathogens; and
- This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.